Literature DB >> 2657522

Nitrofurantoin: an update.

B A Cunha1.   

Abstract

Nitrofurantoin has been in clinical use for more than 35 years for the treatment of urinary tract infections (UTIs). In particular, it has been used to treat acute uncomplicated UTIs, recurrent urinary tract infections, and asymptomatic bacteriuria of pregnancy. Most recently, it has been used for both prophylaxis and treatment of nosocomial infections related to urinary tract instrumentation. Nitrofurantoin is being "rediscovered" for urinary tract infections in obstetrics and gynecology because of its continuing safety record and lack of associated R-factor resistance, compared to recently introduced antimicrobials.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2657522

Source DB:  PubMed          Journal:  Obstet Gynecol Surv        ISSN: 0029-7828            Impact factor:   2.347


  6 in total

Review 1.  [Urinary tract infections and antibiotic resistance].

Authors:  P Heisig
Journal:  Urologe A       Date:  2010-05       Impact factor: 0.639

2.  Comparative Evaluation of Fosfomycin Activity with other Antimicrobial Agents against E.coli Isolates from Urinary Tract Infections.

Authors:  Ahmed Sardar; Sreekanth Reddy Basireddy; Anwar Navaz; Manisha Singh; Vasanti Kabra
Journal:  J Clin Diagn Res       Date:  2017-02-01

3.  Treatment duration of febrile urinary tract infections.

Authors:  Willize E van der Starre; Jaap T van Dissel; Cees van Nieuwkoop
Journal:  Curr Infect Dis Rep       Date:  2011-12       Impact factor: 3.725

Review 4.  A new strategy to fight antimicrobial resistance: the revival of old antibiotics.

Authors:  Nadim Cassir; Jean-Marc Rolain; Philippe Brouqui
Journal:  Front Microbiol       Date:  2014-10-20       Impact factor: 5.640

Review 5.  Role of Old Antibiotics in the Era of Antibiotic Resistance. Highlighted Nitrofurantoin for the Treatment of Lower Urinary Tract Infections.

Authors:  Maria Jose Munoz-Davila
Journal:  Antibiotics (Basel)       Date:  2014-02-10

6.  Assessment of Nitrofurantoin as an Experimental Intracanal Medicament in Endodontics.

Authors:  Mewan Salahalddin A Alrahman; Bestoon Muhammed Faraj; Kawa F Dizaye
Journal:  Biomed Res Int       Date:  2020-02-18       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.